Browse > Article
http://dx.doi.org/10.1007/s10068-018-0399-9

Hypoglycemic effect of standardized Chrysanthemum zawadskii ethanol extract in high-fat diet/streptozotocin-induced diabetic mice and rats  

Kim, Yang-Ji (Food Science R&D Center, KolmarBNH Co., Ltd.)
Kim, Hyun-Kyu (Food Science R&D Center, KolmarBNH Co., Ltd.)
Lee, Hak Sung (Food Science R&D Center, KolmarBNH Co., Ltd.)
Publication Information
Food Science and Biotechnology / v.27, no.6, 2018 , pp. 1771-1779 More about this Journal
Abstract
Chrysanthemum zawadskii (CZ) is a perennial herb belonging to the Asteraceae family. CZ is used medicinally to treat inflammatory and uterine diseases in Asia. CZ was extracted with 50% ethanol and CZ extract (CZE; at 125, 250, and 500 mg/kg body weight) was administered orally every day for 5 or 6 weeks to investigate the anti-diabetic effects in streptozotocin (STZ)-induced rats and STZ + high-fat diet (HFD)-fed mice. CZE significantly decreased fasting blood glucose levels in STZ- and STZ + HFD-induced diabetic models. In addition, glucose tolerance and insulin tolerance were improved in the STZ + HFD + CZE group by increasing insulin levels and decreasing hemoglobin A1c (HbA1c) levels in serum. Furthermore, CZE supplements decreased components of the serum lipid profile such as triglyceride, total cholesterol, and low-density lipoprotein cholesterol levels. These results suggest that CZE may be a potential candidate for controlling hyperglycemia.
Keywords
Chrysanthemum zawadskii; Hyperglycemia; Diabetes; Glucose; Insulin;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 Harris RB, Mitchell TD, Yan X, Simpson JS, Redmann SM. Metabolic responses to leptin in obese db/db mice are strain dependent. Am. J. Physiol. Regul. Integr. Comp. Physiol. 281: 115-132 (2001)   DOI
2 Zheng X, Zhang L, Wang W, Wu Y, Zhang Q, Feng W. Anti-diabetic activity and potential mechanism of total flavonoids of Selaginella tamariscina (Beauv.) Spring in rats induced by high fat diet and low dose STZ. J. Ethnopharmacol. 137: 662-668 (2011)   DOI
3 He J, Chen F, Chen S, Lv G, Deng Y, Fang W, Liu Z, Guan Z, He C. Chrysanthemum leaf epidermal surface morphology and antioxidant and defense enzyme activity in response to aphid infestation. J. Plant Physiol. 168: 687-693 (2011)   DOI
4 Kim M-J, Kim HK. Anti-diabetic effects of electrolyzed reduced water in streptozotocin-induced and genetic diabetic mice. Life Sci. 79: 2288-2292 (2006)   DOI
5 Kim S-J, Cho H-I, Kim S-J, Park J-H, Kim J-S, Kim YH, Lee SK, Kwak J-H, Lee S-M. Protective effect of linarin against d-galactosamine and lipopolysaccharide-induced fulminant hepatic failure. Eur. J. Pharmacol. 738: 66-73 (2014)   DOI
6 Kim YJ, Kim SE, Lee HS, Hong SY, Kim SE, Kim YJ, Lee JH, Park SJ, Kim JH, Park YJ, Kim HK. Comparison of linarin content and biological activity in ethanol extraction of Chrysanthemum zawadskii. J. Korean Soc. Food Sci. Nutr. 45: 1414-1421 (2016)   DOI
7 Liu X, Wu L, Guo X-J. Effect of Bu-Zhong-Yi-Qi-Tang on deficiency of N-glycan/nitric oxide and islet damage induced by streptozotocin in diabetic rats. World J. Gastroenterol. 15: 1730-1737 (2009)   DOI
8 Lemhadri A, Hajji L, Michel J, Eddouks M. Cholesterol and triglycerides lowering activities of caraway fruits in normal and streptozotocin diabetic rats. J. Ethnopharmacol. 106: 321-326 (2006)   DOI
9 Li J, Hao L, Wu J, Zhang J, Su J. Linarin promotes osteogenic differentiation by activating the BMP-2/RUNX2 pathway via protein kinase A signaling. Int. J. Mol. Med. 37: 901-910 (2016)   DOI
10 Liu Q, Liu H, Yuan Z, Wei D, Ye Y. Evaluation of antioxidant activity of chrysanthemum extracts and tea beverages by gold nanoparticles-based assay. Colloids Surf. B Biointerfaces 92: 348-352 (2012)   DOI
11 Reaven GM. Role of insulin resistance in human disease. Diabetes 37: 1595-1607 (1988)   DOI
12 Lou H, Fan P, Perez RG, Lou H. Neuroprotective effects of linarin through activation of the PI3K/Akt pathway in amyloid-${\beta}-induced$ neuronal cell death. Bioorg. Med. Chem. 19: 4021-4027 (2011)   DOI
13 Mertes G. Safety and efficacy of acarbose in the treatment of type 2 diabetes: data from a 5-year surveillance study. Diabetes Res. Clin. Pract. 52: 193-204 (2001)   DOI
14 Moller DE. New drug targets for type 2 diabetes and the metabolic syndrome. Nature. 414: 821-827 (2001)   DOI
15 Seo JY, Lim SS, Park J, Lim JS, Kim HJ, Kang HJ, Park Y, Han J, Kim JS. Protection by Chrysanthemum zawadskii extract from liver damage of mice caused by carbon tetrachloride is maybe mediated by modulation of QR activity. Nutr. Res. Pract. 4: 93-98 (2010)   DOI
16 Reed MJ, Meszaros K, Entes LJ, Claypool MD, Pinkett JG, Gadbois TM, Reaven GM. A new rat model of type 2 diabetes: the fatfed, streptozotocin-treated rat. Metab. Clin. Exp. 49: 1390-1394 (2000)   DOI
17 Saltiel AR. New perspectives into the molecular pathogenesis and treatment of type 2 diabetes. Cell 104: 517-529 (2001)   DOI
18 Sassi AB, Harzallah-Skhiri F, Bourgougnon N, Aouni M. Antimicrobial activities of four Tunisian Chrysanthemum species. Indian J. Med. Res. 127: 183-192 (2008)
19 Sharma AK, Bharti S, Ojha S, Bhatia J, Kumar N, Ray R, Kumari S, Arya DS. Up-regulation of PPAR${\gamma}$, heat shock protein-27 and-72 by naringin attenuates insulin resistance, ${\beta}$-cell dysfunction, hepatic steatosis and kidney damage in a rat model of type 2 diabetes. Br. J. Nutr. 106: 1713-1723 (2011)   DOI
20 Shim SY, Kang HS, Sun HJ, Lee YJ, Park JR, Chun SS, Song YH, Byun DS. Isolation and identification of flavonoids from Gujeolcho (Chrysanthemum zawadskii var. latilobum) as inhibitor of histamine release. Food Sci. Biotechnol. 21: 613-617 (2012)   DOI
21 Woo JH, Lee CH. Effect of harvest date on antioxidant of Dendranthema zawadskii var. latilobum (Maxim.) Kitam and D. zawadskii var. yezoense (Maek.) Y.M. Lee & H.J. Choi. Korean J. Plant Resour. 21: 128-133 (2008)
22 Steiner G, Haynes FJ, Yoshino G, Vranic M. Hyperinsulinemia and in vivo very-low-density lipoprotein-triglyceride kinetics. Am. J. Physiol. 246: 187-192 (1984)
23 Swanston-Flatt SK, Day C, Flatt PR, Gould BJ, Bailey C. Glycaemic effects of traditional European plant treatments for diabetes. Studies in normal and streptozotocin diabetic mice. Diabetes Res. 10: 69-73 (1989)
24 Talpur N, Echard BW, Yasmin T, Bagchi D, Preuss HG. Effects of niacin-bound chromium, Maitake mushroom fraction SX and (-)- hydroxycitric acid on the metabolic syndrome in aged diabetic Zucker fatty rats. Mol. Cell. Biochem. 252: 369-377 (2003)   DOI
25 Wright BE, Vasselli JR, Katovich MJ. Positive effects of acarbose in the diabetic rat are not altered by feeding schedule. Physiol. Behav. 63: 867-874 (1998)   DOI
26 Yudkin J. Sucrose, coronary heart disease, diabetes, and obesity: do hormones provide a link? Am. Heart J. 115: 493-498 (1988)   DOI
27 Zhang FL, Ye C, Li G, Ding W, Zhou W, Zhu H, Chen G, Luo T, Guang M, Liu Y, Zhang D, Zheng S, Yang J, Gu Y, Xie X, Luo M. The rat model of type 2 diabetic mellitus and its glycometabolism characters. Exp. Anim. 52: 401-407 (2003)   DOI
28 Dunn P, Cole R, Soeldner J, Gleason R, Kwa E, Firoozabadi H, Younger D, Graham C. Temporal relationship of glycosylated haemoglobin concentrations to glucose control in diabetics. Diabetologia 17: 213-220 (1979)   DOI
29 Arvind K, Pradeepa R, Deepa R, Mohan V. Diabetes and coronary artery disease. Indian J. Med. Res. 116: 163-176 (2002)
30 DeFronzo RA, Ferrannini E. Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 14: 173-194 (1991)
31 Fratimunari A, Altamiranob E, Rodriguezbarcenas N, Arizaandraca R, Lopezledesma R. Hypoglycemic effect of Opuntia-Streptacantha Lemaire-research with crude extracts. Arch. Invest. Med. (Mex.) 20: 321-325 (1989)
32 Gerich JE. Clinical significance, pathogenesis, and management of postprandial hyperglycemia. Arch. Intern. Med. 163: 1306-1316 (2003)   DOI
33 Han S, Sung KH, Yim D, Lee S, Lee CK, Ha NJ, Kim K. The effect of linarin on LPS-induced cytokine production and nitric oxide inhibition in murine macrophages cell line RAW264.7. Arch. Pharm. Res. 25: 170-177 (2002)   DOI
34 Hanefeld M, Temelkova-Kurktschiev T. The postprandial state and the risk of atherosclerosis. Diabet. Med. 14: 6-11 (1997)   DOI